Biodesix Inc (BDSX) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 to invest. The stock has strong bullish momentum, positive analyst sentiment, and hedge fund buying activity, which align with long-term growth potential.
The technical indicators for BDSX are bullish. The MACD is positively expanding, the RSI is in a neutral zone at 72.335, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock has broken through key resistance levels, with the next resistance at R2: 17.514.

Analysts have raised price targets recently, with Canaccord increasing the target to $27 and H.C. Wainwright initiating coverage with a $26 target. Both firms maintain a Buy rating.
Hedge funds are significantly increasing their buying activity, up 1991.20% over the last quarter.
The stock has a 27.17% chance of increasing in the next month based on historical patterns.
Insiders are selling, with a 531.80% increase in selling activity over the last month.
No recent news or updates on the company's operations or financials.
Financial data for the latest quarter is unavailable, but analysts highlight operating leverage and a path towards sustainable profitability. The company is nearing adjusted EBITDA breakeven.
Analyst sentiment is highly positive. Recent price target increases and Buy ratings from Canaccord and H.C. Wainwright reflect confidence in the company's growth trajectory and operational improvements.